Pfizer begins initial human trial for pill that could cure COVID-19

Leading pharmaceutical giant and one of the most crucial players in the fight against COVID-19, Pfizer, has reportedly announced that it has enrolled several volunteers in initial trials for a new pill, that it hopes could potentially cure COVID-19.

South Africa resumes rollout of J&J COVID-19 vaccine shots

In the past few weeks, Johnson & Johnson’s COVID-19 vaccine has been into headlines over claims of being associated with potential blood clots cases. Speculating this, many countries decided to halt its rollout over concern of public safety. However, after d

South Africa halts use of J&J vaccine over blood clot-related cases

The country has by far lost 53,498 lives to the deadly virus, with 1,561,559 confirmed cases

Following reports of unusual blood clots in people inoculated with Johnson & Johnson’s COVID-19 vaccine, South

Study finds that S. African variant can bypass Pfizer vaccine's shield

A real-world study of data conducted in Israel has reportedly found that the South African variant of the coronavirus possesses the ability to break through the immunity shield created by Pfizer-BioNTech Covid-19 vaccine.


Brazil reports first South African variant case amidst soaring deaths

The Government of Brazil has reportedly announced that the country has detected its first-ever confirmed case of the South African variant. The new case points towards a fresh new sign of danger for a nation that is already being ravaged by the pandemic and reporting

Africa to receive 220Mn doses of single-shot J&J COVID-19 vaccine

In a recent move to accelerate the availability of COVID-19 vaccines, all the African Union member states are slated to gain access to nearly 220 million doses of the Johnson & Johnson (J&J) single-dose coronavirus vaccine, with the ability to order an extra 1

Curevo Vaccine to conduct Phase 1b Trial of Chickenpox Vaccine in SA

The clinical trial includes evaluating tolerability, immunogenicity, and safety of two intramuscular vaccinations for HIV-infected children

U.S. headquartered clinical-stage biopharmaceutical company, Curevo Vaccin

South African business group lobbies vaccine focus on senior citizens

A business lobby group in South Africa has reportedly called on the government to shift the focus of its vaccine program on the elderly as well as the vulnerable, to avoid hospitals being flooded with patients from a third COVID-19 wave.

Countries urge vaccine makers to share vaccine know-how and blueprints

Throughout Southeast Asia and Africa, several aid groups and governments agencies are joining the World Health Organization’s call for pharmaceutical enterprises to share their respective COVID-19 vaccine patent information in an effort to address the yawning global vaccine shortfall more e